Octride 0.1mg Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Octreotide acetate (0.1mg)
Overview Octride 0.1mg Injection
Sandostatin LAR 0.1mg injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, plus aids in preventing post-pancreatic surgery complications. Administration is exclusively by a medical professional; self-injection is prohibited. Dosage and frequency are determined solely by your physician. Consistent use is crucial for optimal therapeutic effect; discontinue only under direct medical supervision. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects to your doctor. Prior to treatment, disclose any liver conditions and a complete list of current medications.
Primary Ingredients of Octride 0.1mg Injection
No information provided. A rephrased version cannot be created.
Uses of Octride 0.1mg Injection
Overgrowth of tissues (acromegaly)|Neuroendocrine tumors (carcinoids)|Esophageal variceal hemorrhage
Major Benefits of Octride 0.1mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Octride 0.1mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Octride 0.1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Octride 0.1mg Injection works:
Octreotide 0.1mg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator. This medication reduces the activity of several hormones, including growth hormone, and diminishes gastrointestinal bleeding by vasoconstriction in the esophagus.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Octride 0.1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Sandostatin LAR 0.1mg injection is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Sandostatin LAR Depot 0.1mg injection is likely compatible with breastfeeding. Available human data indicate minimal infant risk associated with its use.
DrivingSAFE
Administering Octride 0.1mg Injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Octride 0.1mg Injection presents a safe treatment option; no dosage modification is necessary.
LiverCAUTION
Sandostatin LAR 0.1mg injection requires careful administration in individuals with hepatic impairment. Dosage modification for Sandostatin LAR 0.1mg injection may be necessary. Physician consultation is advised.
What if you forget to take Octride 0.1mg Injection :
Should you forget a dose of Octride 0.1mg Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Octride 0.1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Somatostatin Analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Action Class | Somatostatin analogs |



